Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · QQT

Immunohistochemistry Assay, Antibody, Ki-67

The Ki-67 antibody is a qualitative immunohistochemical antibody intended to identify Ki-67 protein expression in human clinical tissue specimens. The KI-67 antibody is indicated as an aid in identifying patients eligible for treatment with specific FDA approved therapeutic drugs.

Product / regulatory recordCompanyPathwayDecision dateSource
Agilent Technologies, Inc.PMA supplementSep 11, 2026FDA
Agilent Technologies, Inc.PMA approvalOct 12, 2021FDA
Source information

Follow the FDA links to view the original records.

All device categories